Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | company profile
Idenix Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile (Global Markets Direct)
- Market: Healthcare and Medical
- Published Date: 01/07/2009
- Report Title: Idenix Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Table of Contents: View Table of Contents
- Report Type: Company Profile
- Country: Global
- Number of Pages: 17
Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and Europe. The Company has developed and commercialized a drug for the treatment of hepatitis B virus that it licensed to Novartis Pharma AG (Novartis). The Company also has developed through proof-of-concept clinical testing a drug candidate (IDX899) for the treatment of human immunodeficiency virus (HIV). In February 2009, the Company entered into a license agreement (GSK License Agreement) with GlaxoSmithKline (GSK) to develop, manufacture and commercialize its NNRTI compounds, including IDX899, for the treatment of human diseases, including HIV/AIDS, on a worldwide basis.More from Reuters »
Idenix Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Idenix Pharmaceuticals, Inc. (Idenix) is a specialized biopharmaceutical company focused in the areas of human viral and other infectious diseases. The company is engaged in the discovery and development of treatments for hepatitis C virus (HCV) and human immunodeficiency virus (HIV). The company is headquartered in Cambridge, Massachusetts, United States.
The Idenix Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick "one-stop-shop" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
Idenix Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Idenix Pharmaceuticals, Inc. (Idenix) is a specialized biopharmaceutical company focused in the areas of human viral and other infectious diseases. The company is engaged in the discovery and development of treatments for hepatitis C virus (HCV) and human immunodeficiency virus (HIV). The company is headquartered in Cambridge, Massachusetts, United States.
The Idenix Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick "one-stop-shop" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
Purchase Information
There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.
Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.
Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
